April 02, 2026

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

Conexiant

April 02, 2026

USDA Alerts on Lead in Walmart Chicken Nuggets

Detected lead could be up to five times FDA’s interim reference level for children

Conexiant

April 02, 2026

Low-Dose Apixaban Cuts Superficial Thrombosis Risk

Extended anticoagulation lowered symptomatic superficial vein thrombosis in patients with provoked venous thromboembolism.

Conexiant

April 01, 2026

FDA Broadens CFTR Therapy Eligibility

The FDA expanded use of CFTR modulators to include more CF gene variants, increasing treatment eligibility across a wider US patient population.

Conexiant

April 01, 2026

Case Report Shows Carbimazole's ‘Triple-Hit’

Diffuse alveolar hemorrhage with coexistent antiphospholipid syndrome complicated anticoagulation therapy and created competing bleeding and thrombosis risks.

Conexiant

April 01, 2026

BMI Patterns in ILD Outcomes Examined

Meta-analysis links higher body mass index to lower mortality and slower lung function decline in interstitial lung disease

Conexiant

April 01, 2026

Visual Snow Challenges Diagnosis

A case highlights persistent visual symptoms despite normal testing and suggests a neurofunctional origin.

Conexiant

April 01, 2026

Bipolar Psychosis: Examining Diagnostic Boundaries

Investigators synthesize schizophrenia comorbidity and psychotic symptom profiles across bipolar populations.

Conexiant

April 01, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Conexiant

March 31, 2026

Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

Conexiant